Complicated Urinary Tract Infection
📧 Sign up to get email alerts when something new happens for Complicated Urinary Tract Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial comparing oral tebipenem pivoxil hydrobromide to intravenous imipenem-cilastatin in adults with complicated urinary tract infe…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of Cefiderocol in Hospitalized Pediatric Participants [Phase 2]
A Phase 2 study assessing safety, tolerability, and pharmacokinetics of cefiderocol in hospitalized pediatric participants has completed wit…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Clinical Performance Evaluation of the QIAstat-Dx® cUTI Plus AMR
The document reports on the clinical performance evaluation of the QIAstat-Dx cUTI Plus AMR diagnostic for complicated urinary tract infecti…
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis [Phase 3]
Phase 3 results comparing cefepime/nacubactam or aztreonam/nacubactam against imipenem/cilastatin for complicated urinary tract infection an…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
A Phase 3 clinical trial evaluating cefepime-zidebactam (FEP-ZID) for complicated urinary tract infection and acute pyelonephritis has compl…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults. [NA]
A completed clinical trial evaluated the clinical utility of PCR testing versus culture and sensitivity for managing complicated urinary tra…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Participants [Phase 2]
Phase 2 pediatric study of cefiderocol in hospitalized children evaluating safety, tolerability, and pharmacokinetics has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Evaluating UTI Outcomes in at Risk Populations
Pathnostics completed a clinical trial evaluating outcomes of urinary tract infections in at-risk populations. The study assessed UTIs and c…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: A Study to Investigate PK, Safety, Tolerability of Cefepime-enmetazobactam in Pediatric Participants With cUTI [Phase 2]
Phase 2 pediatric study assessing pharmacokinetics, safety, and tolerability of cefepime-enmetazobactam in children with complicated urinary…
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis [Phase 2]
Phase 2 clinical trial update for intravenous HRS-8427 in adults with complicated urinary tract infection, including acute pyelonephritis.
-
CLINICAL_TRIALS trial_result · 2023-07-17Clinical Trial Update: Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial update for cefepime-tazobactam in complicated urinary tract infection and acute pyelonephritis; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Evaluation of the Efficacy and Safety of Intravenous Imipenem/Cilastatin/XNW4107 in Comparison With Meropenem in Hospitalized Adults With cUTI Including AP (EudraCT no. 2022-000061-40) [Phase 3]
Phase 3 clinical trial evaluating intravenous imipenem/cilastatin/XNW4107 vs meropenem in hospitalized adults with complicated urinary tract…
-
CLINICAL_TRIALS trial_result · 2022-07-25Clinical Trial Update: Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromide (SPR994) Compared to Intravenous Ertapenem in Participants With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 3]
Phase 3 trial comparing oral tebipenem pivoxil hydrobromide (SPR994) to IV ertapenem in complicated urinary tract infection and acute pyelon…
-
CLINICAL_TRIALS trial_result · 2021-12-01Clinical Trial Update: MK-7625A Versus Meropenem in Pediatric Participants With Complicated Urinary Tract Infection (cUTI) (MK-7625A-034) [Phase 2]
Phase 2 trial comparing MK-7625A to meropenem in pediatric patients with complicated urinary tract infection; study completed with posted re…
-
CLINICAL_TRIALS trial_result · 2021-09-29Clinical Trial Update: Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections [Phase 2]
Phase 2 trial update for meropenem-FL058 in complicated urinary tract infection and acute pyelonephritis.
-
CLINICAL_TRIALS trial_result · 2020-12-29Clinical Trial Update: Sulopenem Followed by Sulopenem-etzadroxil/Probenecid vs Ertapenem Followed by Cipro for Complicated UTI in Adults [Phase 3]
Phase 3 trial comparing sulopenem followed by sulopenem-etzadroxil/probenecid versus ertapenem followed by ciprofloxacin for complicated uri…
-
CLINICAL_TRIALS trial_result · 2020-12-17Clinical Trial Update: Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens [Phase 3]
Phase 3 trial evaluating Cefiderocol (S-649266) versus best available therapy for severe infections due to carbapenem-resistant Gram-negativ…
-
CLINICAL_TRIALS trial_result · 2020-08-10Clinical Trial Update: A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating intravenous benapenem for efficacy and safety in patients with complicated urinary tract infecti…
-
CLINICAL_TRIALS trial_result · 2019-12-12Clinical Trial Update: A Study of Efficacy and Safety of Intravenous Cefiderocol (S-649266) Versus Imipenem/Cilastatin in Complicated Urinary Tract Infections [Phase 2]
Phase 2 trial comparing intravenous cefiderocol to imipenem/cilastatin for complicated urinary tract infections has completed with results p…
-
CLINICAL_TRIALS trial_result · 2019-10-02Clinical Trial Update: Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Participants With Complicated Urinary Tract Infections [Phase 3]
Phase 3 trial comparing eravacycline to ertapenem for complicated urinary tract infections has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2019-09-17Clinical Trial Update: Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) in Japanese Participants With Complicated Intra-abdominal Infection or Complicated Urinary Tract Infection (MK-7655A-017) [Phase 3]
Phase 3 trial evaluating efficacy and safety of imipenem/cilastatin/relebactam (MK-7655A) in Japanese participants with complicated intra-ab…
-
CLINICAL_TRIALS trial_result · 2019-06-05Clinical Trial Update: Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults With Complicated Urinary Tract Infections [Phase 2]
Phase 2 clinical trial evaluating intravenous sulbactam-ETX2514 for hospitalized adults with complicated urinary tract infection and acute p…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections [Phase 2, Phase 3]
Clinical trial update comparing IV fosfomycin (ZTI-01) to piperacillin/tazobactam for complicated urinary tract infections and acute pyelone…
-
CLINICAL_TRIALS trial_result · 2018-12-11Clinical Trial Update: Efficacy and Safety Study of Eravacycline Compared With Levofloxacin in Complicated Urinary Tract Infections [Phase 3]
A Phase 3 clinical trial comparing eravacycline to levofloxacin for complicated urinary tract infections has completed with posted results i…
-
CLINICAL_TRIALS trial_result · 2018-09-19Clinical Trial Update: Study of Ceftolozane/Tazobactam (MK-7625A) in Japanese Participants With Uncomplicated Pyelonephritis and Complicated Urinary Tract Infection (MK-7625A-014) [Phase 3]
Phase 3 trial update of ceftolozane/tazobactam in Japanese participants with uncomplicated pyelonephritis and complicated urinary tract infe…